Procurent of xofluza (baloxavir marboxil) 40MG and 80MG tablets
Active Awarded
- Contract number
- 75A50325F80036
- Awardee
-
Leidos, Inc. UEI E9BSACNAJ7G1
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $37,485,000
Award facts
- Contract value 50% obligated
- $74,970,000.00 Current and potential, with all options
- Completion date 53% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The Office of the Assistant Secretary for Preparedness and Response awarded Leidos, Inc. a delivery order contract valued at approximately $75 million for the procurement of Xofluza (baloxavir marboxil) 40mg and 80mg tablets. The contract, which carries a firm fixed price and no set-aside designation, is scheduled for completion by September 29, 2027, with performance taking place at Leidos QTC Health Services' facility in South San Francisco, California. This procurement is issued under the Multiple Award Schedule (MAS) and represents the government's acquisition of an antiviral medication used to treat influenza infections, supporting the agency's preparedness and response mission.
Leidos, through its National Security Solutions division, leverages its extensive experience delivering critical services across federal health, defense, and civilian sectors to fulfill this pharmaceutical procurement requirement. The company maintains a robust portfolio of federal contracts and IDVs that enable rapid procurement capabilities, positioning it to effectively manage the supply chain and delivery logistics for this medical countermeasure. The contract aligns with the Assistant Secretary for Preparedness and Response's broader mandate to ensure adequate supplies of medical countermeasures and strategic national stockpile initiatives to support public health emergency response capabilities.
Quick answers
Who was awarded contract 75A50325F80036?
75A50325F80036 was awarded to Leidos, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 26, 2025.
How much is contract 75A50325F80036 worth?
The government has obligated $37,485,000 on 75A50325F80036. Its current value, with exercised options, is $74,970,000.
Is contract 75A50325F80036 an order under another contract?
Yes. 75A50325F80036 is a delivery order under GS00F022CA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75A50325F80036 competed?
The extent of competition for 75A50325F80036 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award